Logo image of SSKN

STRATA SKIN SCIENCES INC (SSKN) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:SSKN - US86272A3059 - Common Stock

1.22 USD
-0.05 (-3.94%)
Last: 1/29/2026, 4:34:34 PM
1.2199 USD
0 (-0.01%)
After Hours: 1/29/2026, 4:34:34 PM

SSKN Key Statistics, Chart & Performance

Key Statistics
Market Cap7.19M
Revenue(TTM)30.98M
Net Income(TTM)-11.04M
Shares5.89M
Float4.07M
52 Week High3.86
52 Week Low1.18
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-2.67
PEN/A
Fwd PEN/A
Earnings (Next)03-25
IPO2005-10-28
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
SSKN short term performance overview.The bars show the price performance of SSKN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

SSKN long term performance overview.The bars show the price performance of SSKN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SSKN is 1.22 USD. In the past month the price decreased by -3.94%. In the past year, price decreased by -55.15%.

STRATA SKIN SCIENCES INC / SSKN Daily stock chart

SSKN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SSKN Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to SSKN. Both the profitability and financial health of SSKN have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SSKN Financial Highlights

Over the last trailing twelve months SSKN reported a non-GAAP Earnings per Share(EPS) of -2.67. The EPS decreased by -0.38% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -35.94%
ROE -840.18%
Debt/Equity 10.22
Chartmill High Growth Momentum
EPS Q2Q%32.08%
Sales Q2Q%-21.23%
EPS 1Y (TTM)-0.38%
Revenue 1Y (TTM)-5.19%

SSKN Forecast & Estimates

8 analysts have analysed SSKN and the average price target is 7.55 USD. This implies a price increase of 518.69% is expected in the next year compared to the current price of 1.22.

For the next year, analysts expect an EPS growth of 29.66% and a revenue growth -9.3% for SSKN


Analysts
Analysts85
Price Target7.55 (518.85%)
EPS Next Y29.66%
Revenue Next Year-9.3%

SSKN Ownership

Ownership
Inst Owners19.58%
Ins Owners0.18%
Short Float %7.23%
Short Ratio3.1

About SSKN

Company Profile

SSKN logo image STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. The company is headquartered in Horsham, Pennsylvania and currently employs 106 full-time employees. The company went IPO on 2005-10-28. The firm is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

Company Info

STRATA SKIN SCIENCES INC

5 Walnut Grove Drive, Suite 140

Horsham PENNSYLVANIA 19044 US

CEO: Robert J. Moccia

Employees: 106

SSKN Company Website

SSKN Investor Relations

Phone: 12156193200

STRATA SKIN SCIENCES INC / SSKN FAQ

What does SSKN do?

STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. The company is headquartered in Horsham, Pennsylvania and currently employs 106 full-time employees. The company went IPO on 2005-10-28. The firm is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.


What is the current price of SSKN stock?

The current stock price of SSKN is 1.22 USD. The price decreased by -3.94% in the last trading session.


Does STRATA SKIN SCIENCES INC pay dividends?

SSKN does not pay a dividend.


What is the ChartMill technical and fundamental rating of SSKN stock?

SSKN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Can you provide the sector and industry classification for STRATA SKIN SCIENCES INC?

STRATA SKIN SCIENCES INC (SSKN) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


Can you provide the growth outlook for STRATA SKIN SCIENCES INC?

The Revenue of STRATA SKIN SCIENCES INC (SSKN) is expected to decline by -9.3% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is STRATA SKIN SCIENCES INC worth?

STRATA SKIN SCIENCES INC (SSKN) has a market capitalization of 7.19M USD. This makes SSKN a Nano Cap stock.